Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- DIXON W. M., STRADLING P., WOOTTON I. D. Outpatient P.A.S. therapy. Lancet. 1957 Nov 2;273(7001):871–872. doi: 10.1016/s0140-6736(57)90006-5. [DOI] [PubMed] [Google Scholar]
- JOHNSTON R. N., SMITH D. H., LOCKHART W., RITCHIE R. T. Optimal dose of streptomycin in pulmonary tuberculosis. Br Med J. 1961 Jan 14;1(5219):105–105. doi: 10.1136/bmj.1.5219.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KALINOWSKI S. Z., LLOYD T. W., MOYES E. N. Complications in the chemotherapy of tuberculosis. A review with analysis of the experience of 3,148 patients. Am Rev Respir Dis. 1961 Mar;83:359–371. doi: 10.1164/arrd.1961.83.3.359. [DOI] [PubMed] [Google Scholar]
- MAHADY S. C., ARMSTRONG F. L., BECK F., HORTON R., LINCOLN N. S. A comparative study of streptomycin and dihydrostreptomycin in pulmonary tuberculosis. Am Rev Tuberc. 1953 Aug;68(2):238–248. doi: 10.1164/art.1953.68.2.238. [DOI] [PubMed] [Google Scholar]
- PENMAN A. C., DICKSON I., MILLER J. S. Neurotoxic symptoms in streptomycin therapy: a pilot trial of treatment with pantothenic acid. Tubercle. 1957 Dec;38(6):422–424. doi: 10.1016/s0041-3879(57)80171-8. [DOI] [PubMed] [Google Scholar]
- SIMPSON J. M. Simple tests for the detection of urinary PAS. Tubercle. 1956 Oct;37(5):333–340. doi: 10.1016/s0041-3879(56)80079-2. [DOI] [PubMed] [Google Scholar]
- STRADLING P., POOLE G. Towards foolproof chemotherapy for tuberculosis. Tubercle. 1963 Mar;44:71–75. doi: 10.1016/s0041-3879(63)80060-4. [DOI] [PubMed] [Google Scholar]
- VELU S., ANDREWS R. H., ANGEL J. H., DEVADATTA S., FOX W., JACOB P. G., NAIR C. N., RAMAKRISHNAN C. V. Streptomycin plus pyrazinamide in the treatment of patients excreting isonazid-resistant tubercle bacilli, following previous chemotherapy. Tubercle. 1961 Jun;42:136–147. doi: 10.1016/s0041-3879(61)80089-5. [DOI] [PubMed] [Google Scholar]